Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment

Fig. 3

Mitochondrial activity studies of latency reversal agents. MTT assays were performed on J89GFP lymphocyte and THP89GFP monocyte cell lines during 24 h. Both cell lines were treated with BRY up to 100 nM, PST up to 20 µM, PNB up to 40 nM, and RMD up to 20 nM. Non-treated (NT) cells were used as cell viability control. DMSO was used as cell death control. NT non-treated control, DMSO dimethyl sulfoxide. The mean values (mean ± SD) of three independent experiments are shown (*p < 0.05; **p < 0.005; ***p < 0.001)

Back to article page